Heat shock proteins: Their role in urological tumors

Journal of Urology

Volumn 169, Issue 1, 2003, Pages 338-346

  Lebret, Thierry ^a,b   Watson, R William G ^a,b   Fitzpatrick, John M ^a,b  

^a FOCH HOSPITAL   (France)

^b MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Apoptosis; Heat shock proteins; Heat shock response; Urinary tract; Urologic neoplasms

Indexed keywords

ANTINEOPLASTIC AGENT; CANCER VACCINE; CASPASE; DNA; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; MAJOR HISTOCOMPATIBILITY ANTIGEN; PROTEIN P53; T LYMPHOCYTE RECEPTOR;

APOPTOSIS; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; HUMAN; IMMUNOMODULATION; KIDNEY CARCINOMA; MEDLINE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; TESTIS CANCER; URINARY TRACT CANCER;

EID: 0037213193     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)64123-7     Document Type: Review

References (82)

1. Ritossa, F.: A new puffing pattern induced by temperature shock and DNP in drosophila. Experientia, 18: 571, 1962
2. Kaufmann, S. H.: Heat shock proteins in health and disease. Int J Clin Lab Res, 21: 221, 1992
3. Granel, B., Swiader, L., Serratrice, J., Disdier, P. and Weiller, P. J.: [Heat shock proteins or "stress proteins."] Rev Med Interne, 21: 421, 2000
4. De Maio, A.: The heat-shock response. New Horiz, 3: 198, 1995
5. Kaufman, S. H.: Heat shock proteins and the immune response. Immunol Today, 11: 129, 1990
6. Perdrizet, G. A.: Heat shock and tissue protection. New Horiz, 3: 312, 1995
7. Fuller, K. J., Issels, R. D., Slosman, D. O., Guillet, J. G., Soussi, T. and Polla, B. S.: Cancer and the heat shock response. Eur J Cancer, 30A: 1884, 1994
8. Ciocca, D. R., Oesterreich, S., Chamness, G. C., McGuire, W. L. and Fuqua, S. A.: Biological and clinical implications of heat shock protein 27,000 (Hsp27): A review. J Natl Cancer Inst, 85: 1558, 1993
9. Conroy, S. E. and Latchman, D. S.: Do heat shock proteins have a role in breast cancer? Br J Cancer, 74: 717 1996
10. Ricaniadis, N., Kataki, A., Agnantis, N., Androulakis, G. and Karakousis, C. P.: Long-term prognostic significance or HSP-70, c-myc and HLA-DR expression in patients with malignant melanoma. Eur J Surg Oncol, 27: 88, 2001
11. Dresse, R., Johnson, J. P. and Gunther, E.: Heterogeneous patterns of constitutive and heat shock induced expression of HLA-linked HSP70-1 and HSP70-2 heat shock genes in human melanoma cell lines. Melanoma Res, 8: 482, 1998
12. Nylandsted, J., Brand, K. and Jaattela, M.: Heat shock protein 70 is required for the survival of cancer cells. Ann N Y Acad Sci, 926: 122, 2000
13. Saleh, A., Srinivasula, S. M., Balkir, L., Robbins, P. D. and Alnemri, E. S.: Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat Cell Biol, 2: 475, 2000
14. Finlay, C. A., Hinds, P. W., Tan, T. H., Eliyahu, D., Oren, M. and Levine, A. J.: Activating mutations for transformation by p53 produce a gene product that form an hsc 70-p53 complex with an altered half life. Mol Cell Biol, 8: 531, 1988
15. Jolly, C. and Morimoto, R. I.: Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst, 92: 1564, 2000
16. Finlay, C. A., Hinds, P. W. and Levine, A. J.: The p53 protooncogene can act as a suppressor of transformation. Cell, 57: 1083, 1989
17. Welch, W. J.: Mammalian stress response cell physiology, structure/function of stress proteins and implications for medicine and disease. Physiol Rev, 72: 1063, 1992
18. Sireci, G., Dieli, F. and Salerno, A.: T cell recognize an immunodominant epitope of heat shock protein 65 in Kawasaki disease. Mol Med, 6: 581, 2000
19. Polla, B. S.: A role for heat shock proteins in inflammation? Immunol Today, 9: 134, 1988
20. Multhoff, G., Botzler, C. and Issels, R.: The role of heat shock proteins in the stimulation of an immune response. Biol Chem, 379: 295, 1998
21. Harada, M., Kimura, G. and Nomoto, K.: Heat-shock proteins and the antitumor T cell response. Biotherapy, 10: 229, 1998
22. Craig, E. A.: Chaperones: Helpers along the pathways to protein folding. Science, 260: 1902, 1993
23. Wells, A. D. and Malkkovksy, M.: Heat shock proteins, tumor immunogenicity and antigen presentation: An integrated view. Immunol Today, 21: 129, 2000
24. Liu, C. C., Young, L. H. and Young, J. D.: Lymphocyte-mediated cytolysis and disease. N Engl J Med, 335: 1651, 1996
25. Todryk, S., Melcher, A. A., Hardwick, N., Linardakis, E., Bateman, A., Colombo, M. P. et al: Heat shock protein 70 induced during tumor cell killing induces Thl cytokines and targets immature dentritic cell precursors to enhance antigen uptake. J Immunol, 163: 1398, 1999
26. Srivastava, P. K.: Heat shock proteins in immune response to cancer: The Fourth Paradigm. Experientia, 50: 1054, 1994
27. Zugel, U., Schoel, B., Yamamoto, S., Hengel, H., Morein, B. and Kaufmann, S. H.: Crossrecognition by CD8 T cell receptor alpha beta cytotoxic T lymphocytes of peptides in the self and the mycobacterial hsp60 which share intermediate sequence homology. Eur J Immunol, 25: 451, 1995
28. Multhoff, G., Botzler, C., Jennen, L., Schmidt, J., Ellwart, J. and Issels, R.: Heat shock protein 72 on tumor cells: A recognition structure for natural killer cells. J Immunol, 158: 4341, 1997
29. O'Neill, A. J., Boran, S. A., O'Keane, C., Coffey, R. N., Hegarty, N. J., Hegarty, P. et al: Caspase 3 expression in benign prostatic hyperplasia and prostate carcinoma. Prostate, 47: 183, 2001
30. Beere, H. M., Wolf, B. B., Cain, K., Mosser, D. D., Mahboubi, A., Kuwana, T. et al: Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-I apoptosome. Nat Cell Biol, 2: 469, 2000
31. Sarto, C., Binz, P. A. and Mocarelli, P.: Heat shock proteins in human cancer. Electrophoresis, 21: 1218, 2000
32. Feng, H., Zeng, Y., Whitesell, L. and Katsanis, E.: Stressed apoptotic tumor cells express heat shock proteins and elicit tumor-specific immunity. Blood, 97: 3505, 2001
33. Levine, A. J., Momand, J. and Finlay, C. A.: The p53 tumour suppressor gene. Nature, 351: 453, 1991
34. Thomas, S. A., Brown, I. L., Hollins, G. W., Hocken, A., Kirk, D., King, R. J. et al: Detection and distribution of heat shock proteins 27 and 90 in human benign and malignant prostatic tissue. Br J Urol, 77: 367, 1996
35. Gibbons, N. B., Watson, R. W., Coffey, R. N., Brady, H. P. and Fitzpatrick, J. M.: Heat-shock proteins inhibit induction of prostate cancer cell apoptosis., Prostate, 45: 58, 2000
36. Bostwick, D. G.: Immunohistochemical changes in prostate cancer after androgen deprivation therapy. Mol Urol, 4: 101, 2000
37. Cornford, P. A., Dodson, A. R., Parsons, K. F., Desmond, A. D., Woolfenden, A., Fordham, M. et al: Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res, 60: 7099, 2000
38. Bubendorf, L., Kolmer, M., Kononen, J., Koivisto, P., Mousses, S., Chen, Y. et al: Hormone therapy failure in human prostate cancer: Analysis of complementary DNA and tissue microarrays. J Natl Cancer Inst, 91: 1758, 1999
39. Devaja, O., King, R. J., Papadopoulos, A. and Raju, K. S.: Heat shock protein 27 (HSP27) and its role in female reproductive organs. Eur J Gynaecol Oncol, 18: 16, 1997
40. Castagnetta, L. A. and Carruba, G.: Human cancer prostate: A direct role for oestrogens. Non-reproductive actions sex steroids. CIBA Found Symp, 191: 269 1995
41. Ciocca, D. R. and Elledge, R.: Molecular markers for predicting response to tamoxifen in breast cancer patients. Endocrine, 13: 1, 2000
42. Korneeva, I., Bongiovanni, A. M., Girotra, M., Caputo, T. A. and Witkin, S. S.: IgA antibodies to the 27-kDa heat-shock protein in the genital tracts of women with gynecologic cancers. Int J Cancer, 87: 824, 2000
43. Moriyama-Gonda, N., Igawa, M., Shiina, H., Urakami, S., Wada, Y. and Terashima, M.: Heat-induced cellular damage and tolerance in combination with adriamycin for the PC-3 prostate cancer cell line: Relationships with cytotoxicity, reactive oxygen species and heat shock protein 70 expression. Eur Urol, 38: 235, 2000
44. Paulus, J. A., Tucker, R. D., Flanagan, S. W., Moseley, P. L., Loenig, S. A. and Park, J. B.: Heat shock protein response in a prostate tumor model to interstitial thamotherapy: Implications for clinical treatment. Prostate, 23: 263, 1993
45. Madersbacher, S., Grobl, M., Kramer, G., Dirnhofer, S., Steiner, G. E. and Marberger, M.: Regulation of heat shock protein 27 expression of prostatic cells in response to heat treatment. Prostate, 37: 174, 1998
46. Watson, R. W. G. and Fitzpatrick, J. M.: Target sites for manipulating apoptosis in prostate cancer. BJU Int, Suppl., 85: 38, 2000
47. Roigas, J., Wallen, E. S., Loening, S. A. and Moseley, P. L.: Effects of combined treatment of chemotherapeutics and hyperthermia on survival and the regulation of heat shock proteins in Dunning R3327 prostate carcinoma cells. Prostate, 34: 195, 1998
48. Tucker, R. D., Loening, S. A., Landas, S., Mardan A. H., Ren, Z. Y. and Lubanoff, D. M.: The in vivo effect of regional hyperthera in Dunning R3327 prostatic tumor. Prostate, 18: 321, 1991
49. Colombel, M., Symmons, F., Gil, S., O'Toole, K. M., Chopin D. K., Benzon, M. et al: Detection of apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancer. Am J Pathol, 143: 390, 1993
50. Theodorescu, D., Broder, S. R., Boyd, J. C., Mills, S. E. and Frierson, H. F., Jr.: p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate. J Urol, 158: 131, 1997
51. Nanbu, K., Konishi, I., Mandai, M., Kuroda, H., Hamid, A. A., Komatsu, T. et al: Prognostic significance of heat shock proteins HSP70 and HSP90 in endometrial carcinomas. Cancer Detect Prev, 22: 549, 1998
52. Trieb, K. and Kotz, R.: Proteins expressed in osteosarcoma and serum levels as prognostic factors. Int J Biochem Cell Biol, 33: 11, 2001
53. King, K. L., Li, A. F., Chau, G. Y., Chi, C. W., Wu, C. W., Huang, C. L. et al: Prognostic significance of heat shock protein-27 expression in hepatocellular carcinoma and its relation to histologic grading and survival. Cancer, 88: 2464, 2000
54. Kawanishi, K., Shiozaki, H., Doki, Y., Sakita, I., Inoue, M., Yano, M. et al: Prognostic significance of heat shock proteins 27 and 70 in patients with squamous cell carcinoma of the esophagus. Cancer, 85: 1649, 1999
55. Storm, F. K., Mahvi, D. M. and Gilchrist, K. W.: Hsp-27 has no diagnostic or prognostic significance in prostate or bladder cancers. Urology, 42: 379, 1993
56. Altman, D. G.: Misleading interpretation of results from a small study (letter to the editor). Urology, 43: 411, 1994
57. Cardillo, M. R., Sale, P. and Di Silverio, F.: Heat shock protein-90, IL-6 and IL-10 in bladder cancer. Anticancer Res, 20: 4579, 2000
58. Kamishima, T., Fukuda, T., Usuda, H., Takato, H., Iwamoto, H. and Kaneko, H.: Carcinosarcoma or the urinary bladder: Expression of epithelial markers and different expression of heat shock proteins between epithelial and sarcomatous elements. Pathol Int, 47: 166, 1997
59. Zlotta, A. R., Drowart, A., Huygen, K., De Bruyn, J., Shekarsarai, H., Decock, M. et al Humoral response against heat shock proteins and other mycobacterial antigens after intravesical treatment with bacille Calmette-Guerin (BCG) in patients with superficial bladder cancer. Clin Exp Immunol, 109: 157, 1997
60. Lebret, T., Bohin, D., Kassardjian, Z., Hervé, J. M., Molinié, V., Barré, P. et al: Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations. J Urol, 163: 63, 2000
61. Zlotta, A. R., Drowart, A., Van Vooren, J. P., Shekarsarai, H., De Cock, M., Pirson, M. et al: Superficial bladder tumors and increased reactivity against mycobacterial antigens before bacillus Calmette-Guerin therapy. J Urol, 159: 1885, 1998
62. Lebret, T., Becette, V., Barbagelatta, M., Hervé, J.-M., Gaudez, F., Barré, P. et al: Correlation between p53 over expression and response to bacillus Calmette-Guerin therapy in a high risk select population of patients with T1G3 bladder cancer. J Urol, 159: 788, 1998
63. Pinhasi-Kimhi, O., Michalovitz, D., Ben-Zeev, A. and Oren, M.: Specific interactions between the p53 cellular tumour antigen and major heat shock proteins. Nature, 320: 182, 1986
64. Kaur, J., Srivastava, A. and Ralhan, R.: Serum p53 antibodies in patients with oral lesions: Correlation with p53/HSP70 complexes. Cancer, 74: 609, 1997
65. Richards, E. H., Hickman, J. A. and Masters, J. R.: Heat shock protein expression in testis and bladder cancer cell lines exhibiting differential sensitivity to heat. Br Cancer, 72: 620, 1995
66. Celis, A., Rasmussen, H. H., Celis, P., Basse, B., Lauridsen, J. B., Ratz, G. et al: Short-term culturing of low-grade superficial bladder transitional cell carcinomas leads to changes in the expression levels of several proteins involved in key cellular activities. Electrophoresis, 20: 355, 1999
67. Multhoff, G., Botzler, C., Jennen, L., Schmidt, J., Ellwart J. and Issels, R.: Heat shock protein 72 on tumor cells: A recognition structure for natural killer cells. J Immunol, 158: 4341, 1997
68. Roigas, J., Wallen, E. S., Loening, S. A. and Moseley, P. L.: Heat shock protein (HSP72) surface expression enhance the lysis of a human renal cell carcinoma by IL-2 stimulated NK cells. Adv Exp Med Biol, 451:225, 1998
69. Yoshino, I., Goedegebuure, P. S., Peoples, G. E., Lee, K. Y. and Eberlein, T. J.: Human tumor-infiltrating CD4+ T cells react to B cell lines expressing heat shock protein 70. J Immunol, 153: 4149, 1994
70. Takashi, M., Katsuno, S., Sakata, T., Ohshima, S. and Kato, K.: Different concentrations of two small stress proteins, alphaB crystallin and HSP27 in human urological tumor tissues. Urol Res, 26: 395, 1998
71. Santarosa, M., Favaro, D., Quaia, M. and Galligioni, D.: Expression of heat shock protein 72 in renal cell carcinoma: Possible role and prognostic implications in cancer patients. Eur J Cancer, 33: 873, 1997
72. Sullivan, C. M., Smith, D. M., Matsui, N. M., Andrews, L. E., Clauser, K. R., Chapeaurouge, A. et al: Identification of constitutive and gamma-interferon and interleukin 4-regulated proteins in the human renal cell carcinoma. Cancer Res, 7: 1137, 1997
73. Bergstrom, R., Adami, H. O., Mohner, M., Zatonski, W., Storm, H., Ekhom, A. et al: Increase in testicular cancer incidence in six European countries: A birth cohort phenomenon. J Natl Cancer Inst, 88: 727, 1996
74. Gallagher, R. P., Huchcroft, S., Phillips, N., Hill, G. B., Coldman, A. J., Coppin, C. et al: Physical activity, medical history and risk of testicular cancer (Alberta and British Columbia, Canada). Cancer Causes Control, 6: 398, 1995
75. Socher, S. A., Yin, Y., Dewolf, W. C. and Morgentaler, A.: Heat-induced testicular regression is associated with altered expression of the cell-cycle regulator p53. J Urol, Suppl., 155: 443A, abstract 531, 1996
76. Richards, E. H., Hickey, E., Weber, L. and Master, J. R.: Effect of over expression of the small heat shock protein HSP27 on the heat and drug sensitivities of human testis tumor cells. Cancer Res, 56: 2446, 1996
77. Vargas-Roig, L. M., Gago, F. E., Tello, O., Aznar, J. C. and Ciocca, D. R.: Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy. Int J Cancer, 73: 468, 1997
78. Lukacs, K. V., Pardo, O. E., Colston, M. J., Geddes, D. M. and Alton, E.: Heat shock proteins in cancer therapy. In: Cancer Gene Therapy: Past Achievements and Future Challenges. New York: Kluwer, 2000
79. Lavoie, J. N., Lambert, H., Hickey, E., Weber, L. and Landry, J.: Modulation of cellular thermoresistance and actin filament stability accompanies phosphorylation-induced changes in the dynamic structure of heat shock protein 27. Mol Cell Biol, 15: 505, 1995
80. Wang, X. Y., Kaneko, Y., Repasky, E. and Subjecck, J. R.: Heat shock proteins and cancer immunotherapy. Immunol Invest, 29: 131, 2000
81. Udono, H. and Srivastana, P. K.: Comparison of tumor-specific immunogenicities of stress induced proteins gp96, hsp90 and hsp70. J Immunol, 152: 5398, 1994
82. Yedaveli, S. P. K., Guo, L., Daou, M. E. et al: Preventive and therapeutic effect of tumor derived heat shock protein gp96 in an experimental prostate cancer model. Int J Mol Med, 4: 243, 1994